Published in Stat Med on September 20, 2013
Assessment of refinement of template-based models in CASP11. Proteins (2016) 0.81
Back-transformation of treatment differences--an approximate method. Eur J Clin Nutr (2013) 0.81
Response to comments on 'Log transformation: application and interpretation in biomedical research'. Stat Med (2013) 0.78
Log transformation: application and interpretation in biomedical research. Stat Med (2012) 4.18
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51
Analysis of serial measurements in medical research. BMJ (1990) 16.69
Cronbach's alpha. BMJ (1997) 13.79
Diagnostic tests 2: Predictive values. BMJ (1994) 12.97
The scandal of poor medical research. BMJ (1994) 11.58
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48
Diagnostic tests. 1: Sensitivity and specificity. BMJ (1994) 11.35
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Statistics notes. Logarithms. BMJ (1996) 10.56
Absence of evidence is not evidence of absence. BMJ (1995) 10.36
Statistics in medical journals. Stat Med (1983) 9.80
Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69
Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet (1995) 9.14
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
Statistics and ethics in medical research: III How large a sample? Br Med J (1980) 8.78
Better reporting of randomised controlled trials: the CONSORT statement. BMJ (1996) 8.39
More informative abstracts revisited. Ann Intern Med (1990) 8.26
Statistics notes: the normal distribution. BMJ (1995) 6.82
Transforming data. BMJ (1996) 6.78
Regression towards the mean. BMJ (1994) 6.57
Measurement error. BMJ (1996) 6.18
Comparison of clinical information gained from routine blood-gas analysis and from gastric tonometry for intramural pH. Lancet (1993) 5.90
Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ (1999) 5.86
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA (1994) 5.80
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Statistics notes. The odds ratio. BMJ (2000) 5.61
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol (2001) 5.43
Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol (2003) 5.40
How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet (1999) 5.27
How to randomise. BMJ (1999) 5.24
Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ (1996) 5.18
Air pollution and daily mortality in London: 1987-92. BMJ (1996) 4.97
Comparing several groups using analysis of variance. BMJ (1996) 4.89
Correlation, regression, and repeated data. BMJ (1994) 4.88
Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects. BMJ (1995) 4.87
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Social factors and height of primary schoolchildren in England and Scotland. J Epidemiol Community Health (1978) 4.73
Randomisation. BMJ (1991) 4.66
Patients' preferences and randomised trials. Lancet (1996) 4.64
Measurement error and correlation coefficients. BMJ (1996) 4.38
Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33
Time to event (survival) data. BMJ (1998) 4.29
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
Measurement error. BMJ (1996) 4.13
The natural history of asthma in childhood. J Epidemiol Community Health (1986) 4.09
Survival analysis part I: basic concepts and first analyses. Br J Cancer (2003) 4.08
The intracluster correlation coefficient in cluster randomisation. BMJ (1998) 4.07
Some examples of regression towards the mean. BMJ (1994) 4.01
Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol (2007) 3.84
Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress. BMJ (1989) 3.83
A catalogue of reporting guidelines for health research. Eur J Clin Invest (2010) 3.83
The development of respiratory symptoms in a cohort of Kent schoolchildren. Bull Physiopathol Respir (Nancy) (1975) 3.78
Diagnostic tests 3: receiver operating characteristic plots. BMJ (1994) 3.73
Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth (2002) 3.60
Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study. BMJ (1999) 3.52
Surgery on the rheumatoid cervical spine for the non-ambulant myelopathic patient-too much, too late? Lancet (1996) 3.52
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Transformations, means, and confidence intervals. BMJ (1996) 3.42
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ (1995) 3.35
Measurement error proportional to the mean. BMJ (1996) 3.34
National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. Ann Hum Biol (1977) 3.23
The use of transformation when comparing two means. BMJ (1996) 3.22
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med (1990) 3.18
Interaction 3: How to examine heterogeneity. BMJ (1996) 3.17
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer (2004) 3.15
Incidence of pregnancy after laparoscopy and hydrotubation. Br Med J (Clin Res Ed) (1982) 3.11
Analysis of a trial randomised in clusters. BMJ (1998) 3.10
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. Br J Cancer (2003) 3.06
Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ (1995) 2.94
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units. BMJ (1998) 2.94
Detecting skewness from summary information. BMJ (1996) 2.88
Outcome selection bias in meta-analysis. Stat Methods Med Res (2005) 2.86
Statistics and ethics in medical research. VI--Presentation of results. Br Med J (1980) 2.85
Sample size in cluster randomisation. BMJ (1998) 2.82
The effects of combining education and enforcement to reduce tobacco sales to minors. A study of four northern California communities. JAMA (1991) 2.77
A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc (2001) 2.71
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit. Br J Cancer (2003) 2.71
Baseline comparisons in randomized clinical trials. Stat Med (1991) 2.69
Quartiles, quintiles, centiles, and other quantiles. BMJ (1994) 2.68
Predictors of physician's smoking cessation advice. JAMA (1991) 2.66
More informative abstracts. Ann Intern Med (1987) 2.63
Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet (2001) 2.61
Factors associated with the starting of cigarette smoking by primary school children. Br J Prev Soc Med (1974) 2.61
One and two sided tests of significance. BMJ (1994) 2.61
Long-term study of smoking by secondary schoolchildren. Arch Dis Child (1978) 2.54
Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ (1995) 2.54
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer (1991) 2.29